Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
6(25%)
Results Posted
11%(1 trials)

Phase Distribution

Ph early_phase_1
1
4%
Ph not_applicable
7
29%
Ph phase_2
1
4%
Ph phase_4
1
4%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

6

trials recruiting

Total Trials

24

all time

Status Distribution
Active(8)
Completed(9)
Terminated(2)
Other(5)

Detailed Status

Completed9
Recruiting6
unknown5
Withdrawn2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
24
Active
6
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 21 (10.0%)
Phase 41 (10.0%)
N/A7 (70.0%)

Trials by Status

completed938%
withdrawn28%
not_yet_recruiting28%
unknown521%
recruiting625%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT07280091

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

Recruiting
NCT05532865

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

Recruiting
NCT04272307Early Phase 1

MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.

Completed
NCT06694363

New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

Recruiting
NCT04301401Not Applicable

Assessment of Changes in Vaginal Microbiota Profiles Before and After Vaginal Urogynecologic Surgery

Completed
NCT07337707Not Applicable

New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.

Not Yet Recruiting
NCT02317133

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura

Completed
NCT07078435Not Applicable

Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis

Not Yet Recruiting
NCT06451913Phase 4

Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

Recruiting
NCT07118137

Memory Deterioration in Alzheimer Disease

Recruiting
NCT06235411Not Applicable

Psilocybin in Alcohol Use Disorder With Comorbid Depression

Completed
NCT06161896

Characterization and Clinical Impact of the Gut Microbiota in Lymphoma

Recruiting
NCT02784821Phase 2

Antibiotic "Dysbiosis" in Preterm Infants

Completed
NCT02813590

Ascitic Fluid Microbiome in Liver Cirrhosis

Withdrawn
NCT05543590Not Applicable

Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID

Withdrawn
NCT03359642Not Applicable

Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

Completed
NCT03470506

A Study of the Relationship of Gut Microbial Composition and Stroke Outcome

Unknown
NCT03581201

The Relationship of the Intestinal Microbiome and the Menstrual Cycle

Unknown
NCT03800147Not Applicable

Effects of Nutritional Fat on the Growth of Intestinal E. Coli

Unknown
NCT03494101

Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission

Unknown

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
24